Neurology Topic 1 Ismail Penukonda MD PGY 1 LSUHSC-S, Alexandria, LA
Pre Test CC: 17 yr old AAF with New Onset of Seizures – 5 days Post C-section. Tonic-Clonic Seizure * 3 with urinary incontinence and 30 min post-ictal period after the third seizure. Headache and AMS- Screaming loudly instructing “turn the noise down”. After her fourth seizure in the hospital, the patient was forgetful and seemed to “revert back to
Hx Contd… PMH: Anemia PSH: C-section secondary to IUGR and non-reassuring fetal pattern. First pregnancy. Allergies: NKDA MEDS: Albuterol inhaler PRN & Iron SH: Senior in High School, No smoking/alcohol/illicit drug use. FH: Paternal GF and uncle have ‘seizure disorder’ since childhood.
PE
Vitals: Afebrile, HR: 110, BP: 162/87, RR: 16,Oxygen Sat: 100% on RA. PE: Normal except increased DTR’S. Labs: H/H: 8.1/ 26.9 Platelets: 375 Potassium: 2.5 EKG: Sinus Tachycardia
CXR
MRI
???
What is the Diagnosis?
Clue No.1
Clue No.2
Clue No.3
Common factor
PRESident of USA.
S: Posterior Reversible Encephalopathy Syndrome
ribed in 1996 by Hinchey et al in NEJM
sient, reversible, posterior cerebral edema
dache, nausea, vomiting, altered mental status, seizures, visual disturbances
red vision, visual field loss, and complete cortical blindness
brain reveals characteristic findings
S: Posterior Reversible Encephalopathy Syndrome
• Involve the white matter > cortex
• Completely reversible when promptly recognized and tre
• Patients can progress to ischemia, massive infarction, an • Multiple systemic associations
PRES - Associations:
Toxemia of Pregnancy
Drugs: Cyclosporin Tacrolimus (FK506) Interferon-alpha Flutarabine Cisplatin Gemcitabine Erythropoietin Ifosfamide
5. Others: Hemolytic Uremic Syndrome Hepatorenal Syndrome Acute Intermittent Porphyria HIV Blood Transfusion Post-CEA TTP
Secondary Hypertension: SLE Acute Glomerulonephritis HTN with CRF
Uncontrolled Essential Hypertension
S: Posterior Reversible Encephalopathy Syndrome Pathophysiology: • Posterior cerebral circulation has reduced perivascular sympathetic activity. • Autoregulation in response to hemodynamic challenge (HTN) is insufficient. • Local increases in hydrostatic pressure cause extravasation of fluid. • Regions of vasoconstriction and vasodilatation develop hypoperfusion.
CT
The computed tomography finding is the presence of bilateral and symmetric hypodense areas in the posterior parietal and occipital lobes. This finding can be misdiagnosed as posterior cerebral artery territory infarcts, venous thrombosis, demyelinating disorders, vasculitis and encephalitis.
CT
MRI
Magnetic resonance imaging has important role for diagnosis. MRI show hyperintense lesions on T2weighted images and FLAIR FLAIR: Fluid attenuated inversion recovery. These lesions don’t show enhancement after gadolinium administration. Lesions are typically symmetrical, located in the subcortical white matter and occasionally in the cortex of the occipital and parietal lobes.
MRI
MRI
Diffusion-weighted MR imaging (DWI), including quantification of ADC, is the imaging modality of choice. Cytotoxic edema is caused by acute ischemia, with subsequently decreased ADC (Apparent Diffusion Coefficient) High ADC values are consistent with highly mobile water in areas of vasogenic edema. Quantification of ADC (ADC mapping) is necessary to differentiate cytotoxic edema from vasogenic edema.
DWI
ADC
MRI
CT
Treatment of PRES
Reduction of BP and removal of causative agent.
IV Nicardipine and Labetalol are 1st line agents.
Avoid: Clonidine CNS depression. NTG aggravation of edema due to cerebral vasodilatation.
Identify and treat any systemic disease that may be underlying etiology.
In eclampsia delivery and IV magnesium typically rapid improvement.
Seizure management.
How Reversible is PRES?
Pande et al, 2006
Multicenter retrospective study
53 patients July 1999-June 2003
PRES lesions in the subcortical white matter showed significantly higher reversibility (76-91%) than those in the brain stem (44%), deep white matter (47%) and thalamus (60%).
Complete resolution of radiographic findings occurred in 12/12 with eclampsia, 7/11 with hypertension, 12/21 druginduced, 2/5 renal failure.
Conclusions: Location of lesions and etiology are significant factor in reversibility of PRES.
BEFORE
FLAIR
AFTER 6 D
PRES - Associations:
Toxemia of Pregnancy
Drugs: Cyclosporin Tacrolimus (FK506) Interferon-alpha Flutarabine Cisplatin Gemcitabine Erythropoietin Ifosfamide
5. Others: Hemolytic Uremic Syndrome Hepatorenal Syndrome Acute Intermittent Porphyria HIV Blood Transfusion Post-CEA TTP
Secondary Hypertension: SLE Acute Glomerulonephritis HTN with CRF
Uncontrolled Essential Hypertension
Case 2 CC: Headache and acute bilateral vision loss HPI: 43 year-old female 24 hour hx of HA, nausea/vomiting Awoke with bilateral NLP (No Light Perception) vision.
Hx Contd…
PMH: Relapsing B cell lymphoma dx 10/05 S/P multiple courses of chemo. Wears glasses, No eye disease, No trauma or surgeries Allergies: Codeine, PCN FH: No eye disease SH: Married with 2 children. No tobacco, alcohol, or drug use. ROS: +HA, N/V Meds: Levaquin, Mycofungin, Valtrex, Nystatin, Cyclosporin, Prednisone, Zyrtec, Effexor, Prevacid, MVI
General: Depressed level of consciousness Developed right gaze preference and seizure-like episode. Intubated and treated with IV Ativan at that time.
Labs: Toxicology Screen: Negative CSF: clear, cell count wnl, protein: 43, gram stain -, culture CBC c differential, CMP: WNL
Imaging: CT Head s Contrast: No acute intracranial abnormality
MRI
Cyclosporin: PRES
Cyclosporin inhibits gene transcription of IL-2, IL-3, IFN-g and directly inhibits activation / differentiation of T cells Most common medication associated with PRES Likely secondary to its ability to increase BP and fluid retention Toxic effect on vascular endothelium
Low magnesium, aluminum overload, and high-dose steroids also potentiate toxicity of cyclosporin
Frequently causes hypomagnesaemia and lower seizure threshold
Follow Up
Cyclosporin and Levaquin discontinued, IV antihypertensives, and seizures treated with IV Ativan
Day 3: A+Ox3, HA and N/V resolved. C/O constant blurry vision, Able to read newspaper print with some difficulty
Day 4: Vision returned to baseline per patient
Day 5: Started on FK-506 to replace Cyclosporin
Day 10: Vision 20/20 , no field loss
Case 3
46 y/o woman with recent liver/kidney transplant for EtOH cirrhosis presents to ER with seizures. Seizure at home described as tonic clonic lasting 15 minutes, in ED 2 more focal seizures Associated diffuse headache, visual loss, and tongue biting Not feeling well the day before 2 days prior change in Prograf (Tacrolimus)3 mg bid to 4 mg bid and
Physical Exam
VS: HR 120, BP 157/97, RR 16, T 99.6, Sat 100% GEN: NAD HEENT: MMM CV: Sinus Tachy RR LUNGS: CTAB ABD: Mild pain to palpation diffusely, +BS NEURO: A&Ox2, not following verbal command consistently, poor coordination, visual field deficits and left hemineglect, sensation: left body numbness, reflexes normal
MRI
Management & Follow Up
HTN: Labetalol Seizures: Keppra, Phenytoin Tacrolimus d/c , started on Sirolimus Clinically Improved MRI Improved Discharged , repeat MRI on 1 Month.
Case 3
Back to Case 1: MRI
1. Diffuse bilateral Subdural enhancement suggestive of meningitis. 2. Abnormal T2 and FLAIR signal hyper intensity involving the subcortical white matter and cortex of the post. Parietal and occipital lobes. Clinical correlation for PRES is recommended as follow up. Was the patient hypertensive or eclamptic during
DDx: T2-bright white matter
Neoplastic - glioma, lymphoma, gliomatosis cerebri, metastasis Vascular - arterial or venous thrombosis, anoxia, vasculitis, amyloid angiopathy Demyelination - MS, acute hemorrhagic encephalomelitis, Schilder’s disease, concentric sclerosis Dysmyelination - leukodystrophies, PKU, MSUD Infection Viral - HIV, VZV, JC (PML), measles (SSPE), rubella Bacterial - Lyme, neurosyphilis Parasitic - toxoplasmosis Inflammatory - neurosarcoid, SLE, Behcet’s, Sjogren’s, Wegener’s, polyarteritis nodosa, scleroderma Hydrocephalus - early and normal-pressure Trauma - diffuse axonal injury Seizure Toxic - radiation therapy, antineoplastics, immunosuppressants, drugs of abuse, environmental exposures Posterior Reversible Encephalopathy Syndrome (PRES) Other genetic: NF2, Hurler’s syndrome, mytonic dystrophy
Differential Diagnosis
1. Vascular a. Granulomatous angiitis. b. SLE c. PAN d. PRES: Posterior Reversible Encephalopathy Syndrome 2. Ischemic/Thrombotic a. Ischemic stroke of posterior circulation b. Cerebral Venous Thrombosis 3. Infectious a. Progressive Multifocal Leukoencephalopathy b. Infectious Encephalitis 4. Inflammatory/Demylenating a. Acute Disseminated Encephalomyelitis 5. Mitochondrial Disease a. MELAS: Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like episodes 6. Non-Organic
Back to Case 1
Blood C/S: No growth LP was done with normal CSF studies. CSF C/S : Negative for Malignant Cells/ AFB/Fungal/Viral/Bacterial pathogens. RF: Negative CSF Viral Serology: Negative MS Battery: Negative.
Treatment
Labetalol, Nifedipine, Hydralazine are used to control BP. Seizure control: Depakote and IV Magnesium sulfate. Clinically Improved, Potassium corrected on repletion. Seizure free for 3 days and BP is well controlled and discharged home on Nifedipine. After 2 months she is seizure free and her labs look great.
Post Test
CC: 24 yr old Asian Indian Primi with PIH and started seizing right after delivery and on day 2 has complete bilateral visual loss. Continued to seize for 2 week despite being on Phenytoin and IV MgSo4. BP is tigthly controlled and on third week stopped seizing and regained vision with in a week and discharged home.
Question???
What is the Diagnosis?
Ans: PRES
Thanks!